Rapid emergence and predominance of a broadly recognizing and fast-evolving norovirus GII.17 variant in late 2014

Nature Communications

Volumn 6, Issue , 2015, Pages

  Chan, Martin C W ^a   Lee, Nelson ^a   Hung, Tin Nok ^a   Kwok, Kirsty ^a   Cheung, Kelton ^a   Tin, Edith K Y ^a   Lai, Raymond W M ^a   Nelson, E Anthony S ^a   Leung, Ting F ^a   Chan, Paul K S ^a  

^a Prince of Wales Hospital   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; VIRUS PROTEIN; VIRAL PROTEIN;

ANTIGEN; BAYESIAN ANALYSIS; EMERGENCE; GASTROENTERITIS; GENOTYPE; PROTEIN; SALIVA; VIRUS;

ARTICLE; BLOOD GROUP; CONTROLLED STUDY; GASTROENTERITIS; GENOTYPE; GROUPS BY AGE; HONG KONG; HOSPITALIZATION; HUMAN; IMMUNE EVASION; INFECTION; NONHUMAN; NOROVIRUS; SALIVA; WINTER; ADOLESCENT; ADULT; AGED; AUSTRALIA; CALICIVIRIDAE INFECTIONS; CHILD; CLASSIFICATION; EPIDEMIC; FEMALE; GENETICS; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; MOLECULAR EVOLUTION; MOLECULAR GENETICS; PHYLOGENY; PRESCHOOL CHILD; SEASON; VIROLOGY; YOUNG ADULT;

AUSTRALIA; CHINA; HONG KONG; HONSHU; JAPAN; KANAGAWA; KANTO; KAWASAKI; NEW SOUTH WALES; SYDNEY [NEW SOUTH WALES];

NOROVIRUS;

ADOLESCENT; ADULT; AGED; AUSTRALIA; CALICIVIRIDAE INFECTIONS; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; EVOLUTION, MOLECULAR; FEMALE; GASTROENTERITIS; GENOTYPE; HONG KONG; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NOROVIRUS; PHYLOGENY; SEASONS; VIRAL PROTEINS; YOUNG ADULT;

EID: 84949034565     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms10061     Document Type: Article

References (60)

1. Ahmed, S. M. et al. Global prevalence of norovirus in cases of gastroenteritis: a systematic review and meta-analysis. Lancet Infect. Dis. 14, 725-730 (2014).
2. Zheng, D. P. et al. Norovirus classification and proposed strain nomenclature. Virology 346, 312-323 (2006).
3. Bull, R. A. & White, P. A. Mechanisms of GII.4 norovirus evolution. Trends Microbiol. 19, 233-240 (2011).
4. Desai, R. et al. Severe outcomes are associated with genogroup 2 genotype 4 norovirus outbreaks: a systematic literature review. Clin. Infect. Dis. 55, 189-193 (2012).
5. Chan, M. C., Leung, T. F., Kwok, A. K., Lee, N. & Chan, P. K. Characteristics of patients infected with norovirus GII.4 Sydney 2012, Hong Kong, China. Emerg. Infect. Dis. 20, 658-661 (2014).
6. Boon, D. et al. Comparative evolution of GII.3 and GII.4 norovirus over a 31-year period. J. Virol. 85, 8656-8666 (2011).
7. Sakon, N. et al. Impact of genotype-specific herd immunity on the circulatory dynamism of norovirus: a 10-year longitudinal study of viral acute gastroenteritis. J. Infect. Dis. 211, 879-888 (2015).
8. Kroneman, A. et al. Proposal for a unified norovirus nomenclature and genotyping. Arch. Virol. 158, 2059-2068 (2013).
9. de Graaf, M. et al. Emergence of a novel GII.17 norovirus - End of the GII.4 era? Euro Surveil. 20, pii: 21178 (2015).
10. Tan, M. & Jiang, X. Histo-blood group antigens: a common niche for norovirus and rotavirus. Expert. Rev. Mol. Med. 16, e5 (2014).
11. Bok, K. et al. Evolutionary dynamics of GII.4 noroviruses over a 34-year period. J. Virol. 83, 11890-11901 (2009).
12. Cotten, M. et al. Deep sequencing of norovirus genomes defines evolutionary patterns in an urban tropical setting. J. Virol. 88, 11056-11069 (2014).
13. Eden, J. S. et al. The emergence and evolution of the novel epidemic norovirus GII.4 variant Sydney 2012. Virology 450-451, 106-113 (2014).
14. Lu, J. et al. Gastroenteritis outbreaks caused by norovirus GII.17, Guangdong Province, China, 2014-2015. Emerg. Infect. Dis. 21, 1240-1242 (2015).
15. Fu, J. et al. Emergence of a new GII.17 norovirus variant in patients with acute gastroenteritis in Jiangsu, China, September 2014 to March 2015. Euro Surveill. 20, pii: 21157 (2015).
16. Matsushima, Y. et al. Genetic analyses of GII.17 norovirus strains in diarrheal disease outbreaks from December 2014 to March 2015 in Japan reveal a novel polymerase sequence and amino acid substitutions in the capsid region. Euro Surveill. 20, pii: 21173 (2015).
17. Vega, E. et al. Genotypic and epidemiologic trends of norovirus outbreaks in the United States, 2009 to 2013. J. Clin. Microbiol. 52, 147-155 (2014).
18. Bernard, H., Hohne, M., Niendorf, S., Altmann, D. & Stark, K. Epidemiology of norovirus gastroenteritis in Germany 2001-2009: eight seasons of routine surveillance. Epidemiol. Infect. 142, 63-74 (2014).
19. Greening, G. E., Hewitt, J., Rivera-Aban, M. & Croucher, D. Molecular epidemiology of norovirus gastroenteritis outbreaks in New Zealand from 2002-2009. J. Med. Virol. 84, 1449-1458 (2012).
20. Lau, C. S. et al. High rate and changing molecular epidemiology pattern of norovirus infections in sporadic cases and outbreaks of gastroenteritis in Hong Kong. J. Med. Virol. 73, 113-117 (2004).
21. Ho, E. C., Cheng, P. K., Wong, D. A., Lau, A. W. & Lim, W. W. Correlation of norovirus variants with epidemics of acute viral gastroenteritis in Hong Kong. J. Med. Virol. 78, 1473-1479 (2006).
22. Chan, M. C. et al. Fecal viral load and norovirus-associated gastroenteritis. Emerg. Infect. Dis. 12, 1278-1280 (2006).
23. Kiulia, N. M., Mans, J., Mwenda, J. M. & Taylor, M. B. Norovirus GII.17 predominates in selected surface water sources in Kenya. Food Chem. Toxicol. 6, 221-231 (2014).
24. Galeano, M. E. et al. Molecular epidemiology of norovirus strains in Paraguayan children during 2004-2005: description of a possible new GII.4 cluster. J. Clin. Virol. 58, 378-384 (2013).
25. Mans, J., Murray, T. Y. & Taylor, M. B. Novel norovirus recombinants detected in South Africa. Virol. J. 11, 168 (2014).
26. Ayukekbong, J. A. et al. Pattern of circulation of norovirus GII strains during natural infection. J. Clin. Microbiol. 52, 4253-4259 (2014).
27. Robilotti, E., Deresinski, S. & Pinsky, B. A. Norovirus. Clin. Microbiol. Rev. 28, 134-164 (2015).
28. Debbink, K. Ancestry-based differences in norovirus susceptibility: implications for understanding global infection patterns. Clin. Infect. Dis. 60, 1639-1641 (2015).
29. Currier, R. L. et al. Innate susceptibility to norovirus infections influenced by FUT2 genotype in a United States pediatric population. Clin. Infect. Dis. 60, 1631-1638 (2015).
30. Liu, W. et al. A unique human norovirus lineage with a distinct HBGA binding interface. PLoS Pathog. 11, e1005025 (2015).
31. de Rougemont, A. et al. Qualitative and quantitative analysis of the binding of GII.4 norovirus variants onto human blood group antigens. J. Virol. 85, 4057-4070 (2011).
32. Ruvoen-Clouet, N., Belliot, G. & Le Pendu, J. Noroviruses and histo-blood groups: the impact of common host genetic polymorphisms on virus transmission and evolution. Rev. Med. Virol. 23, 355-366 (2013).
33. Leshem, E. et al. Genotype GI.6 norovirus, United States, 2010-2012. Emerg. Infect. Dis. 19, 1317-1320 (2013).
34. Vega, E. & Vinje, J. Novel GII.12 norovirus strain, United States, 2009-2010. Emerg. Infect. Dis. 17, 1516-1518 (2011).
35. Franck, K. T., Fonager, J., Ersboll, A. K. & Bottiger, B. Norovirus epidemiology in community and health care settings and association with patient age, Denmark. Emerg. Infect. Dis. 20, 1123-1131 (2014).
36. Mattner, F. et al. Risk groups for clinical complications of norovirus infections: an outbreak investigation. Clin. Microbiol. Infect. 12, 69-74 (2006).
37. van Asten, L. et al. Mortality attributable to 9 common infections: significant effect of influenza A, respiratory syncytial virus, influenza B, norovirus, and parainfluenza in elderly persons. J. Infect. Dis. 206, 628-639 (2012).
38. Siebenga, J. J. et al. Epochal evolution of GGII.4 norovirus capsid proteins from 1995 to 2006. J. Virol. 81, 9932-9941 (2007).
39. Noel, J. S., Fankhauser, R. L., Ando, T., Monroe, S. S. & Glass, R. I. Identification of a distinct common strain of "Norwalk-like viruses" having a global distribution. J. Infect. Dis. 179, 1334-1344 (1999).
40. Lopman, B. et al. Increase in viral gastroenteritis outbreaks in Europe and epidemic spread of new norovirus variant. Lancet 363, 682-688 (2004).
41. Bull, R. A., Eden, J. S., Rawlinson, W. D. & White, P. A. Rapid evolution of pandemic noroviruses of the GII.4 lineage. PLoS Pathog. 6, e1000831 (2010).
42. Duffy, S., Shackelton, L. A. & Holmes, E. C. Rates of evolutionary change in viruses: patterns and determinants. Nat. Rev. Genet. 9, 267-276 (2008).
43. Domingo, E. & Holland, J. J. RNA virus mutations and fitness for survival. Annu. Rev. Microbiol. 51, 151-178 (1997).
44. Lindesmith, L. C. et al. Mechanisms of GII.4 norovirus persistence in human populations. PLoS Med. 5, e31 (2008).
45. Donaldson, E. F., Lindesmith, L. C., Lobue, A. D. & Baric, R. S. Viral shapeshifting: norovirus evasion of the human immune system. Nat. Rev. Microbiol. 8, 231-241 (2010).
46. Green, K. Y. & Parra, G. I. Genome of emerging norovirus GII.17, United States, 2014. Emerg. Infect. Dis. 21, 1477-1479 (2015).
47. Chan, M. C. & Chan, P. K. Complete genome sequence of a novel recombinant human norovirus genogroup II genotype 4 strain associated with an epidemic during summer of 2012 in Hong Kong. Genome Announc 1, pii: e00140-12 (2013).
48. Victoria, M. et al. Bayesian coalescent inference reveals high evolutionary rates and expansion of Norovirus populations. Infect. Genet. Evol 9, 927-932 (2009).
49. Pybus, O. G. et al. Phylogenetic evidence for deleterious mutation load in RNA viruses and its contribution to viral evolution. Mol. Biol. Evol. 24, 845-852 (2007).
50. Sukhrie, F. H. et al. Using molecular epidemiology to trace transmission of nosocomial norovirus infection. J. Clin. Microbiol. 49, 602-606 (2011).
51. de Andrade Jda, S. et al. Noroviruses associated with outbreaks of acute gastroenteritis in the State of Rio Grande do Sul, Brazil, 2004-2011. J. Clin. Virol. 61, 345-352 (2014).
52. Chan, M. C. et al. Covariation of major and minor viral capsid proteins in norovirus genogroup II genotype 4 strains. J. Virol. 86, 1227-1232 (2012).
53. Vongpunsawad, S., Venkataram Prasad, B. V. & Estes, M. K. Norwalk virus minor capsid protein VP2 associates within the VP1 shell domain. J. Virol. 87, 4818-4825 (2013).
54. Bertolotti-Ciarlet, A., Crawford, S. E., Hutson, A. M. & Estes, M. K. The 3′ end of Norwalk virus mRNA contains determinants that regulate the expression and stability of the viral capsid protein VP1: a novel function for the VP2 protein. J. Virol. 77, 11603-11615 (2003).
55. Chan, M. C. et al. Virus genotype distribution and virus burden in children and adults hospitalized for norovirus gastroenteritis, 2012-2014, Hong Kong. Sci. Rep 5, 11507 (2015).
56. Kageyama, T. et al. Broadly reactive and highly sensitive assay for Norwalk-like viruses based on real-time quantitative reverse transcription-PCR. J. Clin. Microbiol. 41, 1548-1557 (2003).
57. Hansman, G. S. et al. Structural basis for broad detection of genogroup II noroviruses by a monoclonal antibody that binds to a site occluded in the viral particle. J. Virol. 86, 3635-3646 (2012).
58. Vega, E. et al. RNA populations in immunocompromised patients as reservoirs for novel norovirus variants. J. Virol. 88, 14184-14196 (2014).
59. Chan, M. C., Ho, W. S. & Sung, J. J. In vitro whole-virus binding of a norovirus genogroup II genotype 4 strain to cells of the lamina propria and Brunner's glands in the human duodenum. J. Virol. 85, 8427-8430 (2011).
60. Lindesmith, L. C. et al. Immunogenetic mechanisms driving norovirus GII.4 antigenic variation. PLoS Pathog. 8, e1002705 (2012).